FOCUS UNIVERSAL INC. (FCUV): Nasdaq/NYSE listing notice — Focus Universal receives Nasdaq delisting notice for MVPHS below $15M

FOCUS UNIVERSAL INC.

Received Nasdaq letter on May 9, 2024: MVPHS below $15M for 32 consecutive trading days.
Must regain compliance by Nov 5, 2024; else may transfer to Nasdaq Capital Market (MVPHS min $1M).
No immediate effect on listing; stock continues trading on Nasdaq Global Market during 180-day period.
Company to evaluate options including transfer application to Nasdaq Capital Market.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

FOCUS UNIVERSAL INC. received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(2)(C), 5450(b)(3)(C), 5810(c)(3)(A), 5810(c)(3)(C)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: market value
Rules: 5450(b)(2)(C), 5450(b)(3)(C), 5810(c)(3)(A), 5810(c)(3)(C)

Exact text from the filing

May 9, 2024, Focus Universal Inc. (the “ Company ”), received a letter from the Listing Qualifications Department (the “ Staff ”) of the Nasdaq Stock Market (“ Nasdaq ”). The May 9, 2024, letter was notifying the Company that based on the Staff’s review of the Company’s Market Value of Publicly Held Shares (“ MVPHS ”), the Company’s MVPHS has fallen below the required minimum of $15,000,000 for the last 32 consecutive business days. Therefore, the Company no longer meets the Nasdaq Listing Rule 5450(b)(2)(C) and 5450(b)(3)(C) (the “ MVPHS Rules ”). The notification received has no immediate ef

View on SEC.gov

5 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

FOCUS UNIVERSAL INC. filing history →

Source: SEC EDGAR

accession 0001683168-24-003251

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.